Table of Contents
Chemotherapy Research and Practice
Volume 2012 (2012), Article ID 817304, 9 pages
Review Article

Advances in Targeting HER3 as an Anticancer Therapy

1State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangdong, Guangzhou 510060, China
2Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, 1365-C Clifton Road, NE, Atlanta, GA 30322, USA

Received 7 June 2012; Accepted 10 October 2012

Academic Editor: Missak Haigentz

Copyright © 2012 Ning Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ning Jiang, Nabil F. Saba, and Zhuo Georgia Chen, “Advances in Targeting HER3 as an Anticancer Therapy,” Chemotherapy Research and Practice, vol. 2012, Article ID 817304, 9 pages, 2012. doi:10.1155/2012/817304